Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Extreme Prematurity: later-stage trial registry
2 of 6 indexed Extreme Prematurity trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Extreme Prematurity: 6 US clinical trials tracked, 2 recruiting.
Extreme Prematurity is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Sharp HealthCare, running 2 of these trials.
Enrollment posture brief
Registry condition extreme-prematurity
OPEN 2 | RECR 33% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Extreme Prematurity lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Extreme Prematurity on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Extreme Prematurity is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Extreme Prematurity research.
Sharp HealthCare accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Extreme Prematurity enrolment sits around 310 participants.
Median target enrolment is 310 among the 6 trials that report a genuine target (sentinel values excluded). 2 of those (33.3%) plan for fewer than 100 participants.
-
Extreme Prematurity splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Dopamine vs. Norepinephrine for Hypotension in Very Preterm Infants With Late-onset Sepsis
Mount Sinai Hospital, Canada
NCT05347238
Ventilator Pressure and Optimization of Compliance and Hemodynamics
University of Alabama at Birmingham
NCT06512935
NICU Antibiotics and Outcomes Trial
Michael Morowitz
NCT03997266
Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants
Sharp HealthCare
NCT04413097
Prediction of Brain Injury in Premature Infants
Baylor College of Medicine
NCT02814383
Time to Accurate Heart Rate on Neonatal Outcomes
Sharp HealthCare
NCT04587934
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Extreme Prematurity records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Extreme Prematurity trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Extreme Prematurity page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Extreme Prematurity trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sharp HealthCare sponsors the most Extreme Prematurity trials on record, review their full trial history before evaluating a specific study. See Sharp HealthCare's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Extreme Prematurity condition card totals 6 registered trials; most-linked intervention Brain Monitoring Platform; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.